Presentations about Oxford Gene Technology's (OGT's) array-comparative genomic hybridisation (aCGH) solutions were held at the recent European Human Genetics Conference in Sweden.
Entitled 'From disease to cytogenetics research - An integrated CNV analysis platform from OGT', delegates heard presentations from researchers on how OGT's aCGH solutions can help advance disease and cytogenetics research.
The three presentations were: 'Genome-wide association study of copy-number variation in 16,000 cases of eight common diseases and 3,000 shared controls' from Dr Vincent Plagnol at University College London Genetics Institute (UGI) and the JDRF/WT Diabetes and Inflammation Laboratory at Cambridge University; 'An International Standard Cytogenomic Array (ISCA) Consortium approach to the design, implementation and reporting of constitutional oligo array-CGH' from John A Crolla of the Wessex Regional Genetics Laboratory in Salisbury; and 'How to ensure the highest-quality CNV data' from OGT's Spencer Howell.
During the workshop, OGT announced that its Cytosure Interpret Software can now transfer aCGH aberration data directly to Cartagenia's Bench constitutional cytogenetics platform, enabling cytogeneticists to accurately correlate genotypic findings with known clinical phenotypes.
